AI summary by TwinMind
Vaccine Efficacy Numbers, Explained | WSJ
The Wall Street Journal
6m 0s
Vaccine Efficacy vs Effectiveness Definitions
- Efficacy: Performance under ideal, tightly controlled clinical trial conditions
- Pfizer original trials: 95% efficacy rate
- Tested ~44,000 people for symptomatic COVID-19
- Only 170 developed disease with symptoms (8 vaccinated, 162 placebo)
- Means 95% fewer people contract disease in vaccinated population vs individual immunity
- Effectiveness: Real-world performance outside clinical settings
- Variables harder to control (vaccination timing, immune system differences, behavioral changes)
- Generally lower than efficacy numbers from trials
Israeli Study Results
- Recent unpublished data from Israel (June-July collection period)
- Pfizer vaccine only 40% effective at reducing symptomatic COVID risk
- Same study showed 91% effectiveness against hospitalization and death
- Breakthrough cases more likely in people vaccinated early (January-February)
Factors Contributing to Reduced Effectiveness
- Delta variant dominance: More transmissible than earlier strains
- Became dominant months after vaccine authorization
- Current vaccines designed for earlier coronavirus version
- Don't work as well against Delta
- Waning immunity: Antibodies naturally decrease over time
- Changed conditions:
- Original trials during lockdowns, mask-wearing, limited gatherings
- Current real-world: businesses open, large gatherings resumed
- People not getting vaccines at exact intervals
Breakthrough Cases Data
- US states counted over 190,000 breakthrough cases (January 1st - early August)
- Among millions already vaccinated
- Cases usually mild, don't result in severe illness
Booster Shot Recommendations
- Biden administration announced booster plan for fully vaccinated adults 18+
- Goal: Keep immunity high enough before it wanes
- Should increase chances vaccines prevent severe illness, hospitalization, death
- Some debate among public health experts about current necessity
Additional Immune Defenses
- Antibodies not body's only defense
- Certain immune cells prepare body to fight pathogens
- These cells may not be waning like antibodies
Expert Recommendations
- Lisa Lee (30 years virus spread study experience, CDC leadership roles)
- Vaccine efficacy depends on:
- Virus contagiousness (infection rate without vaccine)
- Host immune response stimulation
- Vaccines help "slow the speeding car" and reduce transmission
- Additional preventive measures recommended: mask wearing, social distancing
